
In the highly technical and competitive landscape of the life science industry—whether selling capital equipment, reagents, or CRO services—the difference between a closed deal and a stalled opportunity may lie in information visibility. While scientific expertise and relationship-building remain critical, the modern life science sales environment demands a rigorous, data-driven approach.
A question frequently asked by commercial leaders in the life sciences is: How can we empower our sales teams with tangible data that directly contributes to increased win rates? This article explores the critical role that marketing-generated data can have in helping business development teams navigate complex scientific sales cycles and outlines strategies for leveraging account engagement insights to close active deals.
Sales cycles for capital research equipment, software systems, or scientific services are notoriously protracted. They often extend over months or beyond a year, involving a complex "Buying Committee" that can include Principal Investigators (PIs), Lab Managers, Procurement Officers - and depending on the product or service, the C-suite or specific groups like IT or even Environmental Health and Safety (EHS) personnel may become involved.
During these lengthy engagements, several factors complicate the process. Take for example some of the challenges in an example capital research equipment sale:
Without data visibility, navigating these cycles is inefficient if the salesperson can’t address the specific concerns of the buying committee members. Sales teams need real-time insights not just to bring in new leads, but to understand the nuances of active opportunities.
There is significant confusion about the utility of marketing data for sales. Sales professionals in the life sciences are often focused on direct technical consultation. Consequently, they may view marketing metrics—such as web site engagement, email content clicks, webinar attendance or whitepaper downloads—as nice to know, but not wholly relevant to their open deals. And marketing teams may consider their responsibility “done” once a qualified lead is handed to sales, thinking at that point winning the business sits wholly with the sales team.
This is a critical oversight. In the life sciences, content consumption may be a direct proxy for technical intent. And the most effective marketing teams continue to support sales along the entire buying cycle. But challenges exist:
While data is a key part of lead generation and nurturing, an equally important value of account-level data in the life sciences applies to managing existing open opportunities. Once a deal is in the pipeline, the sales representative’s primary challenge is maintaining momentum and alignment with the buying committee.
Access to granular account engagement data changes the dynamic in several specific ways:
If an opportunity has stalled, data can reveal why.
In complex equipment sales, the decision-maker is rarely a single individual. Data allows the sales team to see who is engaging.
In long sales cycles, there may be times where a sales rep is naturally waiting on the buyer. Perhaps the target account has told the rep to wait, or the project has been delayed. If someone from the target account is seen to have registered for a webinar, or downloaded content, this can provide the sales team a low pressure way to follow up and re-engage with the buyer - while addressing something that is likely relevant to the buyer.
Consider a manufacturer of high-end flow cytometry equipment. The typical sales cycle is 6–12 months and the price point exceeds $200k.
To operationalize this, organizations must implement a dashboard that translates digital signals into actionable sales information.
Key Components for Scientific Sales:
In the life science industry, where products are complex and stakes are high, data acts as the radar for the sales team. By leveraging account engagement data, sales leaders can do more than just identify leads; they can uncover the hidden variables in active deals, identify the changing cast of characters in the buying committee, and tailor their scientific consulting to the exact needs of the moment. Empowering the team with this data transitions them from reactive vendors to proactive partners, directly increasing their win rate, and allows marketing to be seen as a true partner to the sales and BD teams.



Our work helps teams turn complex data into growth — driving qualified leads, higher engagement, and stronger campaign performance across every channel.